Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia

被引:612
作者
Allen, TM
O'Connor, DH
Jing, PC
Dzuris, JL
Mothé, BR
Vogel, TU
Dunphy, E
Liebl, ME
Emerson, C
Wilson, N
Kunstman, KJ
Wang, XC
Allison, DB
Hughes, AL
Desrosiers, RC
Altman, JD
Wolinsky, SM
Sette, A
Watkins, DI
机构
[1] Univ Wisconsin, Wisconsin Reg Primate Res Ctr, Madison, WI 53715 USA
[2] Epimmune, San Diego, CA 92121 USA
[3] Northwestern Univ, Sch Med, Chicago, IL 60611 USA
[4] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA
[5] St Lukes Roosevelt Hosp, Obes Res Ctr, New York, NY 10025 USA
[6] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA
[7] New England Reg Primate Res Ctr, Southborough, MA 01772 USA
[8] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA
关键词
D O I
10.1038/35030124
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections are characterized by early peaks of viraemia that decline as strong cellular immune responses develop(1,2). Although it has been shown that virus-specific CD8-positive cytotoxic T lymphocytes (CTLs) exert selective pressure during HIV and SIV infection(3-11), the data have been controversial(12,13). Here we show that Tat-specific CD8-positive T-lymphocyte responses select for new viral escape variants during the acute phase of infection. We sequenced the entire virus immediately after the acute phase, and found that amino-acid replacements accumulated primarily in Tat CTL epitopes. This implies that Tat-specific CTLs may be significantly involved in controlling wild-type virus replication, and suggests that responses against viral proteins that are expressed early during the viral life cycle might be attractive targets for HIV vaccine development.
引用
收藏
页码:386 / 390
页数:6
相关论文
共 28 条
[1]   Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen [J].
Allen, TM ;
Vogel, TU ;
Fuller, DH ;
Mothé, BR ;
Steffen, S ;
Boyson, JE ;
Shipley, T ;
Fuller, J ;
Hanke, T ;
Sette, A ;
Altman, JD ;
Moss, B ;
McMichael, AJ ;
Watkins, DI .
JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4968-4978
[2]  
Allen TM, 1998, J IMMUNOL, V160, P6062
[3]  
ALLEN TM, IN PRESS J VIROL
[4]   Phenotypic analysis of antigen-specific T lymphocytes [J].
Altman, JD ;
Moss, PAH ;
Goulder, PJR ;
Barouch, DH ;
McHeyzerWilliams, MG ;
Bell, JI ;
McMichael, AJ ;
Davis, MM .
SCIENCE, 1996, 274 (5284) :94-96
[5]   United Kingdom - Modest Briton stirs up storm with views on role of CTLs [J].
Balter, M .
SCIENCE, 1998, 280 (5371) :1860-1861
[6]   Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus [J].
Borrow, P ;
Lewicki, H ;
Wei, XP ;
Horwitz, MS ;
Peffer, N ;
Meyers, H ;
Nelson, JA ;
Gairin, JE ;
Hahn, BH ;
Oldstone, MBA ;
Shaw, GM .
NATURE MEDICINE, 1997, 3 (02) :205-211
[7]   Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine [J].
Cafaro, A ;
Caputo, A ;
Fracasso, C ;
Maggiorella, MT ;
Goletti, D ;
Baroncelli, S ;
Pace, M ;
Sernicola, L ;
Koanga-Mogtomo, ML ;
Betti, M ;
Borsetti, A ;
Belli, R ;
Åkerblom, L ;
Corrias, F ;
Buttò, S ;
Heeney, J ;
Verani, P ;
Titti, F ;
Ensoli, B .
NATURE MEDICINE, 1999, 5 (06) :643-650
[8]   HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J].
COFFIN, JM .
SCIENCE, 1995, 267 (5197) :483-489
[9]   HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes [J].
Collins, KL ;
Chen, BK ;
Kalams, SA ;
Walker, BD ;
Baltimore, D .
NATURE, 1998, 391 (6665) :397-401
[10]   IMPAIRED CYTOTOXIC T-LYMPHOCYTE RECOGNITION DUE TO GENETIC VARIATIONS IN THE MAIN IMMUNOGENIC REGION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS-1 NEF PROTEIN [J].
COUILLIN, I ;
CULMANNPENCIOLELLI, B ;
GOMARD, E ;
CHOPPIN, J ;
LEVY, JP ;
GUILLET, JG ;
SARAGOSTI, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) :1129-1134